Reuters logo
9 个月前
BRIEF-Amgen and Cytokinetics say Lancet published results from Phase 2 clinical trial evaluating omecamtiv mecarbil
2016年11月30日 / 晚上11点52分 / 9 个月前

BRIEF-Amgen and Cytokinetics say Lancet published results from Phase 2 clinical trial evaluating omecamtiv mecarbil

Nov 30 (Reuters) - Cytokinetics Inc

* Says Amgen and co announced Lancet published results from a Phase 2 clinical trial evaluating omecamtiv mecarbil

* Cytokinetics - statistically significant improvements in all pre-specified secondary measures

* Cytokinetics Inc says Adverse Events (AES), including serious AES, in patients on omecamtiv mecarbil were comparable to placebo Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below